Oblimersen for the treatment of patients with chronic lymphocytic leukemia.
about
The Successful Use of Enoxaparin in the Lack of Bivalirudin in a Patient with Chronic Lymphocytic Leukemia and Thrombocytopenia who Underwent Percutaneous Coronary Revascularization.Principles of microRNA involvement in human cancers.Targeted nanoparticle delivery overcomes off-target immunostimulatory effects of oligonucleotides and improves therapeutic efficacy in chronic lymphocytic leukemia.A covalently stabilized lipid-polycation-DNA (sLPD) vector for antisense oligonucleotide deliveryPhase I and pharmacologic study of SNS-032, a potent and selective Cdk2, 7, and 9 inhibitor, in patients with advanced chronic lymphocytic leukemia and multiple myeloma.Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia.Personalized medicine in CLL: current status and future perspectives.Chronic lymphocytic leukemia: interplay between noncoding RNAs and protein-coding genesChemosensitization of prostate cancer by modulating Bcl-2 family proteins.Induction of apoptosis by a potent caffeic acid derivative, caffeic acid undecyl ester, is mediated by mitochondrial damage in NALM-6 human B cell leukemia cells.Transferrin receptor-targeted lipid nanoparticles for delivery of an antisense oligodeoxyribonucleotide against Bcl-2.
P2860
Q33419923-E141B1D2-5C20-479E-A2C6-D8AE528565DBQ33579255-A559EA73-0400-43E4-BBA3-4E6D418B6770Q36512593-E3C3BA16-A25D-405E-A9D0-624ED968DB0BQ36691274-35824C3F-BF06-4BD0-8F3E-9B3A4F73FBDFQ37163806-2F55FE03-1C7B-4854-966D-1CAB313780B2Q37187536-EFB1DF74-6469-4CF8-8D96-871FA1D6825CQ37412148-C98BB139-6636-46AC-92DB-7E02105D5F1CQ37450534-B019A033-BF46-4919-8D7A-CF4FF144CF9FQ37713757-1A084E50-080B-4EED-A428-C7DDD41D5973Q39228259-80D60BE6-8704-4409-B5DA-3B6E6D5D0A6DQ39323667-96E0BF4D-9470-4432-AA34-DE2D0DDB4BE1
P2860
Oblimersen for the treatment of patients with chronic lymphocytic leukemia.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Oblimersen for the treatment of patients with chronic lymphocytic leukemia.
@ast
Oblimersen for the treatment of patients with chronic lymphocytic leukemia.
@en
type
label
Oblimersen for the treatment of patients with chronic lymphocytic leukemia.
@ast
Oblimersen for the treatment of patients with chronic lymphocytic leukemia.
@en
prefLabel
Oblimersen for the treatment of patients with chronic lymphocytic leukemia.
@ast
Oblimersen for the treatment of patients with chronic lymphocytic leukemia.
@en
P2860
P1476
Oblimersen for the treatment of patients with chronic lymphocytic leukemia.
@en
P2093
Bruce D Cheson
P2860
P304
P577
2007-10-01T00:00:00Z